Masimo Corporation is a global medical technology company dedicated to improving patient outcomes and reducing the cost of care through innovative noninvasive monitoring technologies. The company's mission is to enhance the quality of patient care by providing advanced monitoring solutions that deliver accurate and reliable data. Masimo's strategy focuses on continuous innovation and expanding its product offerings, including pulse oximetry and other noninvasive monitoring devices, to meet the evolving needs of healthcare providers. Through its commitment to research and development, Masimo aims to lead the market in noninvasive monitoring and improve clinical decision-making worldwide.

MASIMO CORP

Masimo Corporation has experienced a significant turnaround, reporting improved earnings and a bullish outlook after its fourth-quarter earnings report for 2024. Following the announcement, shares surged over 8%, reflecting investor confidence in the company's direction under new CEO Katie Szyman. Szyman is steering the company to concentrate on its core...

Masimo Reports Strong Q4 Earnings and Raises 2025 Guidance Amid Strategic Realignment Under New CEO